SCHEMBL10166151

SCHEMBL10166151

COc1cncc(-c2cc(C(=O)NCc3ccc4ccccc4c3)c(N3CCOCC3)nn2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 4/20 0.57
HCRTR1 O43613 2/20 0.45
TP53 P04637 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
THRB P10828 1/20 0.43
PDE4B Q07343 2/20 0.42
HDAC1 Q13547 2/20 0.42
ACHE P22303 1/20 0.42
UBE2I P63279 1/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
UBA2 Q9UBT2 1/20 0.42
DYRK1A Q13627 2/20 0.41
GSK3B P49841 1/20 0.41
HDAC3 O15379 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10166441 0.90 HCRTR2 (0.58) HCRTR2HCRTR1TP53THRBHDAC1
SCHEMBL10166866 0.89 HCRTR2 (0.58) HCRTR2HCRTR1TP53HDAC1ACHE
SCHEMBL10166451 0.89 TP53 (0.51) HCRTR2HCRTR1TP53ALDH1A1HDAC1
SCHEMBL666604 0.83 HCRTR2 (0.40) HCRTR2HCRTR1POLBDYRK1AGSK3B
SCHEMBL10165791 0.83 TP53 (0.51) HCRTR2TP53THRBHDAC1ACHE
SCHEMBL667539 0.81 HCRTR2 (0.78) HCRTR2HCRTR1TP53KDM4EPOLB
SCHEMBL667759 0.81 HCRTR2 (0.80) HCRTR2HCRTR1TP53KDM4EPOLB
SCHEMBL667564 0.76 HCRTR2 (0.89) HCRTR2HCRTR1TP53KDM4EALDH1A1
SCHEMBL667753 0.73 HCRTR2 (0.41) HCRTR2HCRTR1DYRK1AGSK3B
SCHEMBL667875 0.73 HCRTR2 (1.00) HCRTR2HCRTR1TP53KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046289-A1 Pyridazine Carboxamide Orexin Receptor Antagonists MERCK SHARP & DOHME CORP. 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046289-A1 Pyridazine Carboxamide Orexin Receptor Antagonists HCRTR2, HCRTR1, NPY5R HCRTR2 1/4885HCRTR1 2/4885TP53 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.